| Central Precocious Puberty Caused by Novel Mutations in the Promoter and 5′-UTR Region of the Imprinted MKRN3 Gene P Fanis, N Skordis, M Toumba, N Papaioannou, A Makris, A Kyriakou, ... Frontiers in Endocrinology 10, 677, 2019 | 28 | 2019 |
| Distinct miRNA signatures and networks discern fetal from adult erythroid differentiation and primary from immortalized erythroid cells PL Papasavva, NY Papaioannou, P Patsali, R Kurita, Y Nakamura, ... International journal of molecular sciences 22 (7), 3626, 2021 | 15 | 2021 |
| Context base editing for splice correction of IVSI-110 β-thalassemia B Naiisseh, PL Papasavva, NY Papaioannou, M Tomazou, L Koniali, ... Molecular Therapy-Nucleic Acids 35 (2), 2024 | 5 | 2024 |
| High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis NY Papaioannou, P Patsali, B Naiisseh, PL Papasavva, L Koniali, ... Frontiers in Genome Editing 5, 1141618, 2023 | 2 | 2023 |
| Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by HBBAS3 Gene Addition and Mutation-Specific RNA Interference L Koniali, C Flouri, MI Kostopoulou, NY Papaioannou, PL Papasavva, ... Cells 12 (24), 2848, 2023 | 1 | 2023 |
| HBBIVSI-110 (G> A)-specific gene editing as advanced therapy for beta-thalassemia B Naiisseh, NY Papaioannou, P Papasavva, C Lardou, L Koniali, ... HUMAN GENE THERAPY 33 (23-24), A69-A70, 2022 | | 2022 |
| Optimisation of mutation-specific TALEN-and CRISPR/Cas9-based gene correction therapy for ss-thalassaemia P Patsali, PL Papasavva, C Mussolino, NY Papaioannou, S Christou, ... HUMAN GENE THERAPY 33 (23-24), A142-A142, 2022 | | 2022 |
